holmium has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, B; Cutler, CS; Dadachova, E; Francesconi, LC; Jiang, Z; Miller, WH; Revskaya, E; Sisay, N; Thompson, S | 1 |
| Choi, CW; Han, BH; Kim, EH; Kim, GE; Kim, KH; Lee, JD; Lee, MG; Park, JH; Park, KB; Ryu, YH; Seong, JS; Shin, KH; Suh, CO; Yang, WI | 1 |
2 other study(ies) available for holmium and B16 Melanoma
| Article | Year |
|---|---|
166Ho and 90Y labeled 6D2 monoclonal antibody for targeted radiotherapy of melanoma: comparison with 188Re radiolabel.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Drug Stability; Female; Half-Life; Holmium; Humans; Melanoma, Experimental; Mice; Mice, Nude; Pentetic Acid; Radioimmunotherapy; Tissue Distribution; Yttrium Radioisotopes | 2014 |
Effective local control of malignant melanoma by intratumoural injection of a beta-emitting radionuclide.
Topics: Animals; Autoradiography; bcl-2-Associated X Protein; Beta Particles; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Genes, p53; Holmium; Injections, Intralesional; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radioisotopes; Radionuclide Imaging; RNA, Messenger; RNA, Neoplasm; Tumor Suppressor Protein p53 | 2002 |